Navigation Links
Most Not Worried by Delayed Prostate Cancer Therapy
Date:7/27/2009

Little anxiety noted in survey of men who opt out of aggressive treatment

MONDAY, July 27 (HealthDay News) -- Men who delay treatment for their early prostate cancer are not especially anxious about living with the disease, new Dutch research shows.

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues. The findings are published in the Sept. 1 issue of Cancer.

The researchers surveyed 129 men regarding their levels of depression and anxiety over their treatment decision. More than 80 percent scored favorably low and compared well emotionally with patients who had opted for more aggressive treatment, the study found.

Men who were in poor general health and those with neurotic personalities expressed higher levels of anxiety and distress, suggesting that factors other than cancer may impact a patient's emotional response, the researchers noted.

The study is especially useful in an era when prostate-specific antigen tests and other screening exams are uncovering prostate cancer at increasingly earlier stages. Many physicians practice a "wait-and-see" approach to treatment, saving the more aggressive therapies for when the cancer grows or spreads, according to information in a news release from the American Cancer Society.

Nationally, prostate cancer is one of the most common cancers and is expected to strike more than 190,000 men this year, and result in over 27,000 deaths, according to the American Cancer Society. But thanks to more effective screenings and treatments, while one in six U.S. men will develop prostate cancer during their lifetime, only one in 35 will actually die of the disease. What's more, there are more than 2 million men in the United States who have been diagnosed with prostate cancer at some point and are still alive today, according to the society.

More information

The U.S. National Cancer Institute has more on prostate cancer.



-- Peter West



SOURCE: American Cancer Society, news release, July 27, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Work Atmosphere Is Worried, Panicky, Say Majority of U.S. Employees
2. Older Workers Worried About Promised Medicare and Social Security Benefits, Watson Wyatt Survey Finds
3. Worried Your Pet Will Get Lost or Stolen? Invest in Pet Identification
4. New Poll Shows Public Worried About Medicare Cuts Impact on Seniors, Boomers - Wants Congress To Act
5. Independent Voters Remain Worried about Health Care
6. Solvay Pharmaceuticals, Inc. Announces Commercial Availability of CREON(R) (Pancrelipase) Delayed-Release Capsules
7. KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10-K
8. Video: CREON(R) (Pancrelipase) Delayed-Release Capsules First and Only Pancreatic Enzyme Product to Receive FDA Approval Under New Guidelines
9. KAPIDEX(TM) (dexlansoprazole) delayed release capsules Now Available for the Treatment of GERD
10. KV Pharmaceuticals Launch of Gestiva(TM) Delayed
11. Mylan Receives Final FDA Approval for Generic Version of Prilosec(R) Delayed-Release Capsules, 40 mg
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Most Not Worried by Delayed Prostate Cancer Therapy
(Date:7/20/2017)... ... ... Buffalo and Her Adventures”: a collection of heartwarming children’s stories. “Lucky the Buffalo and ... was born in Toledo, Ohio. He attended Woodward High School. He earned an ... a brilliant woman with a caring heart named Tiina, who is a hospice nurse. ...
(Date:7/18/2017)... ... 18, 2017 , ... Cognition Corporation , a software ... sessions of its “From the Helm” Webinar Series. , These sessions will ... Cognition’s CEO, the half-hour public webinars will take an in-depth look at applying ...
(Date:7/18/2017)... Calif. (PRWEB) , ... July 18, 2017 , ... The results of an international clinical ... a drug therapy for a severe type of muscular dystrophy holds promise for a subgroup ... , Craig McDonald and colleagues at 53 study sites in 18 countries describe ...
(Date:7/18/2017)... ... July 18, 2017 , ... An inventor from Anacortes, Wash., knows ... menopause, I have frequent hot flashes, and I suffer from anxiety and vertigo on ... keep cool while out and about." INSTA-FAN meets that need. , This device enables ...
(Date:7/18/2017)... (PRWEB) , ... July 18, 2017 , ... Heritage Woods ... from 11 a.m. to 12:30 p.m. on Aug. 15. , The community, which is ... including those on Medicaid, who need some help to maintain their independence. , The ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... July 10, 2017  BDI Group subsidiary Pathway ... support services organization serving specialty pharmacies, home infusion ... of four significant, value-added member programs designed to ... manage reimbursement and improve access and affordability for ... Pathway ...
(Date:7/10/2017)... 10, 2017 Locus Biosciences Inc. today announced ... the development of CRISPR-Cas3 antimicrobial therapeutics. Financing for the ... Chinese Internet services provider, and joined by the North ... disease product programs targeting antibiotic resistant infections and other ... by Dr. Rodolphe Barrangou and Dr. ...
(Date:7/5/2017)... , July 5, 2017 Wolfmet 3D  printed ... as physics and manufacturing combine to progress molecular radiotherapy imaging. ... SPECT systems are unable to accurately quantify the radiation absorbed ... information regarding the success of this radiotherapy treatment has been ... ...
Breaking Medicine Technology: